identified the chemical odor signature of volatile organic compounds (vocs) a.k.a. smell associated with the metabolism of covid-19 infection in a human or non-human. the team went on to tune their associated ai algorithms to achieve an almost faultless 100% detection accuracy in 5 seconds. the company was granted the first real-time covid detection patent on 29 dec 2020, u.s. patent number us 10,880,303 real-time covid-19 outbreak identification with non-invasive, internal imaging for dual biometric authentication and biometric health monitoring its fourth patent issued in two years, on march 15, 2022, they were granted u.s. patent number 11,277,405 dual biometric authentication and biometric health monitoring using chemosensory and internal imaging data. in april 2022, the fda authorized for emergency use the first covid-19 diagnostic test using breath samples. "the inspectir covid-19 breathalyzer uses a technique called gas chromatography gas mass-spectrometry (gc-ms) to separate and identify chemical mixtures and rapidly detect five volatile organic compounds (vocs) associated with sars-cov-2 infection in exhaled breath," said the fda.